Marketplace:
Third Nerve's patent pending discovery approach is unique in the marketplace. Our system overcomes problems commonly encountered in the single-entity, static collaboration, joint venture and subsidiary research environments that have proliferated to date. While avoiding the traditional obstacles, we realize new benefits in efficiency and economy.
With Third Nerve you gain access to the latest technologies without saddling your organization with large capital expenditures for new equipment and the burden of increased staffing. We enable specialty organizations to participate in efforts ordinarily out of practical reach. Larger or more deeply funded entities can explore multiple avenues simultaneously. Across the board we help companies to focus on their core competencies through proper integration into large-scale efforts building demand for their products and services.
Our research subscriptions offer both a "try-before-you-buy" scenario for companies interested in acquiring new technologies and a real-world audition for those wishing to place their tools and abilities in the life sciences market.
Management:
Third Nerve benefits from key personnel guiding decisions in both science and business.
Science Contact
|
Herbert A. Fritsche, Ph.D.
|
|
Dr. Fritsche has performed cancer and tumor marker research for over 35 years. He is widely published and a frequent lecturer at conferences around the globe. He sits on the scientific advisory boards of a number of life sciences companies.
|
Business Contact
|
Trey Rossiter, MBA
|
|
Mr. Rossiter has worked in information technology for 20 years. He founded a forecasting and data analysis consulting company which he operated for nearly six years before moving into bioinformatics. Over the last five years his primary focus has been in biomedical informatics.
|
